Background
Human adenoviruses (HAdV) are non-enveloped double-stranded DNA viruses. They belong to the family
Adenoviridae. Approximately 103 genotypes of HAdV have been documented to date. They are organized into seven species (A-G) [
1,
2]. HAdV is a highly contagious pathogen that causes various clinical illnesses, including upper and lower respiratory tract infections, bronchitis, pneumonia, conjunctivitis, and acute gastroenteritis [
3]. All age groups of people are susceptible to HAdV infections, while children, immunocompromised patients, cardiovascular disease patients, and military trainees are at a higher risk for developing severe disease [
3‐
5]. It has been reported that HAdV is responsible for at least 5–10% of pediatric and 1–7% of adult respiratory tract infections (RTIs) [
6]. HAdV infections have a worldwide distribution, but the distribution of adenovirus subtypes often differs by geographical region or human population. Among all HAdVs, types 3, 4, 7, 14, 21, and 55 often cause severe infections and have been linked to outbreaks globally [
7‐
11]. HAdV-associated outbreaks are more likely to occur in closed and crowded conditions, such as schools, hospitals, or military recruits [
7,
9].
In recent years, an increasing number of HAdV outbreaks have been reported in China. An acute respiratory infection (ARI) outbreak caused by a re-emergent isolate of HAdV55 occurred in Shanxi Province in 2006 [
12]. An outbreak of febrile respiratory illness caused by HAdV-14p1 occurred in Gansu Province in 2011 [
13]. Two outbreaks of acute respiratory diseases caused by HAdV-7 were detected in military training camps, one in Hubei Province and another in Shaanxi Province between 2012 and 2013 [
7]. HAdV-B3 was also frequently reported as the common cause of epidemic ARI outbreaks in China [
14]. However, limited data are available regarding the epidemiological and clinical features of HAdV in hospitalized patients. In this study, we sought to determine the prevalence and subtypes of HAdVs among hospitalized patients with RTIs in Guangzhou, China. Such epidemiological data are useful to health professionals regarding decisions in employing appropriate therapy and adopting effective prevention strategies for adenovirus control.
Materials and methods
Patients and specimens
Nasal swab (NS) specimens (n = 4129) were initially obtained from hospitalized patients with RTIs at the Second Affiliated Hospital of Guangzhou University of Chinese Medicine between August 2017 and October 2019. These patients were recruited for participation in the hospital’s study if they met the following inclusion criteria: (i) had a fever (temperature ≥ 37.3 °C, measured at the hospital) with the apparent respiratory symptom(s); (ii) did not have the bacterial infection (patients with white blood cell count > 12 × 10^9/L, or procalcitonin (PCT) > 0.5 ng/L were excluded from this study). Individuals who met the inclusion criteria were consented (parental consent required for adolescents under the age of 18) and invited to complete a brief questionnaire about their demographics and symptoms.
Subject sample collection
Each participant permitted the collection of one NS specimen (the swab stayed in the nose for 15 s), which was placed in viral transport media (COPAN Diagnostics Inc., Italy), stored in the icebox, and then transported to the hospital’s laboratory. Specimens were preserved at − 80 °C until further processing.
At the hospital’s laboratory, all clinical NS specimens (n = 4129) were first screened with the commercially available Immunofluorescence assay (respiratory viral panel 1 screening and identification kit, Light DiagnosticTM, Chemicon International Inc., Temecula, USA) targeting adenovirus, influenza A and B virus, parainfluenza 1–3, and respiratory syncytial virus (RSV). A total of 117 HAdV-positive specimens were detected using the Immunofluorescence assay. No HAdV-positive casses were co-infected with other respiratory viruses (e.g., Influenza A/B virus, PIV1-3, or RSV). Later these HAdV-positive specimens were sent to the Duke Kunshan University (DKU) One Health Research Laboratory to be used for this study.
Detection of HAdV with real-time PCR
At the DKU One Health Research Laboratory, DNA was extracted from HAdV-positive specimens and eluted in 60 μl of elution buffer using a QIAamp MinElute Virus Spin Kit (Cat. No.57704, Qiagen Inc., Hilden, Germany). Extracted DNA was then tested for adenovirus by real-time quantitative polymerase chain reaction (qPCR) assays using a BioRad SsoAdvanced Universal Probes Supermix (Bio-Rad Laboratories, Richmond, CA) as previously described [
15] on a Mic qPCR Cycler (BioMolecular Systems, EI Cajon, CA). Positive and negative template controls were included in each qPCR run. The qPCR cycling was run as follows: 90 °C for 2 min, 95 °C for 3 min, followed by 40 cycles of 95 °C for 15 s, and 60 °C for 30s. Samples with quantification cycles (Cq) values < 38 were considered positive for adenovirus.
Nested PCR targeting the HAdV hexon gene’s hyper-variable regions 1–6 (HVR1–6) was performed for genotyping (predicted amplicon size: 764–896 base pairs (bp) [
16]. The outer primers used in the first-round amplification were AdhexF1 (5′-TGTAAAACGACGGCCAGT-TICTTTGACATICGIGGIGTICTIGA-3′) and AdhexR1 (5′-CTGTCIACIGCCTGRTTCCACA-3′). The inner primers used in a second PCR were AdhexF2 (5′-GGYCCYAGYTTYAARCCCTAYTC-3′) and AdhexR2 (5′-GGTTCTGTCICCCAGAGARTCIAGCA-3′). Nested PCR was conducted in a 50 μl volume comprising 5 μl of 10x PCR buffer (−Mg), 0.2 μl (50 μM) of each primer, 1.0 μl of dNTP Mix, 1.5 μl of 50 mM MgCI2, 0.2 μl of Taq DNA Polymerase, 0.5 μl of first nested-PCR product, and 41.4 μl of double-distilled water. Cycling conditions were employed as follows: 94 °C for 2 min, followed by 36 cycles at 94 °C for 1 min, 45 °C for 1 min, and 72 °C for 2 min, and a 5 min extension at 72 °C. PCR products were analyzed on 2% agarose gels and sent for sequencing.
Sequence and phylogenetic analysis
Hexon gene nucleotide sequences from the specimens collected in this study were aligned with multiple reference strains available in GenBank (accession numbers are listed in Supplementary Table
1) using ClustalW. The phylogenetic tree was constructed by the neighbor-joining method with bootstrap analysis (
n = 1000) by MEGA7.0 software.
Statistical analysis
STATA version 15.0 (StataCorp LP, College Station, TX) was used for statistically analysis. The demographic data was analyzed for statistical significance using the Chi-square test or Fisher’s exact test as appropriate. Kruskal-Wallis test was employed for comparisons between two or more groups. The two-tailed value of P < 0.05 was considered as statistically significant.
Discussion
The present study recorded the epidemiological distribution of circulating HAdV strains among hospitalized patients with RTIs between 2017 and 2019 in Guangzhou City, China.
In this study, the overall positive rate of HAdV was 2.4%, which is consistent with the positive rate (2.0–6.1%) found in hospitalized patients with acute viral respiratory infection in recent reports in China, Israel, and Switzerland [
3,
17‐
20]. However, two previous studies conducted in the Northern part of China showed a higher HAdV prevalence (10.4–20.1%) than our study [
21,
22]. These findings indicate that HAdV prevalence may differ by geographic locations. Such differences in HAdV prevalence could be influenced by a number of other factors, including clinical sample type, patients’ ages, patients’ occupations, patients’ underlying diseases, and sampling period during the patients’ illnesses.
HAdVs are considered one of the major causes of acute respiratory diseases in children and adults worldwide [
6,
23,
24]. HAdVs are more prevalent in young children and responsible for approximately 2–10% of pediatric RTIs annually [
20,
22]. Our findings are consistent with such worldwide observations in that we found 96% (95 of 99) of the study’s HAdV-positive patients to be less than ten years of age.
Our study revealed that although HAdV infections were detected throughout the year, the prevalence peaked in the summer. This is consistent with findings of Chen et al. [
25] during 2012–2013. But it was not consistent with that of studies conducted in Northern China [
21] and Mexico [
26]. In Tanzania and Switzerland, HAdV infections were observed during all seasons of the year with no clear seasonality demonstrated [
19,
27]. These difference in HAdV prevalence between seasons are interesting and bear future study as seasonal risk could influence future employment of HAdV vaccines which are in development in China [
28].
In this study, seven HAdV types were identified: HAdV-B3, HAdV-B7, HAdV-B55, HAdV-C1, HAdV-C2, HAdV-C5, and HAdV-E4. Among these types, HAdV-B3 and HAdV-B7 were most prevalent which is consistent with other reports in Asia [
29‐
31]. The majority (94.6%) of HAdV types detected in this study were of species B. HAdV-B (e.g., 3, 7, and 55) has been continuously reported to be associated with more severe acute respiratory disease than other HAdVs species [
2,
14,
32]. Additionally, HAdV-B3 and -B7 were the subtypes that have been frequently found in Shenzhen and Guangzhou in recent years [
3,
25,
29,
33]. These two cities are 139.3 km adjacent to each other and are both located in the Guangdong province of China. HAdV-B3 and B7 identified in this study were also highly identical to strains detected in Shenzhen, which indicates the conservation of hexon genes of these two subtypes within Guangdong province. Only seven patients were found to have HAdV-C, and eight patients were found to have HAdV-E infection during the study period.
Previously, three types of HAdV-C (e.g., 1, 2, and 5) were identified in China, although studies of HAdV-C species have been limited [
34]. HAdV-C species viruses were identified as the primary pathogens responsible for respiratory tract infections among hospitalized children, particularly among infants under two years of age [
34]. Our study is consistent with this in that more than half of HAdV-C-positive patients were observed in children less than two years old. Previous research suggests that recombination events are commonly observed among HAdV-C types [
34]. As recombinant HAdV strains have caused epidemics, it seems prudent to monitor for changes in HAdV-C types in China.
Although our study provides crucial molecular evidence regarding the epidemiology and clinical features of HAdV infections in Guangzhou, China, it has several limitations. First, we did not study outpatients and they could have had a different distribution of HAdV subtypes. Second, study samples were first identified using a commercial assay which is not thought to be as sensitive as the qPCR we employed. Hence, we likely only captured data on the specimens with higher viral titers. Thus, the true prevalence of HAdV among hospitalized patients may have been higher and the distribution of HAdV subtypes different. Third, according to the laboratory results provided by the collaborated hospital, we did not find any adenovirus-positive patients in this study infected with influenza A/B, PIV 1–3, and RSV at the same time. In addition, we were unable to rule out all other possible respiratory viruses in specimens except HAdV, influenza A/B virus, PIV1–3, and RSV. Hence, we cannot compare the epidemiological results of single infection and coinfections. Future studies may consider using non-targeted metagenomic sequencing approach to explore more information regarding the coinfection issue.
Adenovirus surveillance is important to China. A recent multicenter, prospective registry study found that HAdV was the third-leading cause of viral infection among community-acquired pneumonia patients in China after influenza viruses and respiratory syncytial virus [
35]. Additionally, antivirals [
36,
37] and vaccines [
28,
38] against adenovirus infections are seen on the horizon for China. Even so, China has not yet established a national surveillance system for HAdVs, which seems to be greatly needed. Nationwide, periodic HAdV surveillance could alert Chinese public health officials of the emergence of pre-pandemic or particularly virulent strains and help them mitigate the threat.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.